These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19913246)

  • 1. Validation of the partin nomogram for prostate cancer in a national sample.
    Yu JB; Makarov DV; Sharma R; Peschel RE; Partin AW; Gross CP
    J Urol; 2010 Jan; 183(1):105-11. PubMed ID: 19913246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
    Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
    BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.
    Jeong CW; Jeong SJ; Hong SK; Lee SB; Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE
    Int J Urol; 2012 Sep; 19(9):846-52. PubMed ID: 22587373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
    Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
    J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of the updated Partin tables in a cohort of North American men.
    Karakiewicz PI; Bhojani N; Capitanio U; Reuther AM; Suardi N; Jeldres C; Pharand D; Péloquin F; Perrotte P; Shariat SF; Klein EA
    J Urol; 2008 Sep; 180(3):898-902; discussion 902-3. PubMed ID: 18635222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
    Makarov DV; Trock BJ; Humphreys EB; Mangold LA; Walsh PC; Epstein JI; Partin AW
    Urology; 2007 Jun; 69(6):1095-101. PubMed ID: 17572194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Partin tables suitable for Chinese patients with prostate cancer?
    Shen XC; Qiu YQ; Zheng YC; Zhang SZ
    Chin Med J (Engl); 2012 Nov; 125(21):3795-9. PubMed ID: 23106876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
    Zorn KC; Capitanio U; Jeldres C; Arjane P; Perrotte P; Shariat SF; Lee DI; Shalhav AL; Zagaja GP; Shikanov SA; Gofrit ON; Thong AE; Albala DM; Sun L; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1461-7. PubMed ID: 18938046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive ability of partin tables 2001 in a Welsh population.
    Ayyathurai R; Ananthakrishnan K; Rajasundaram R; Knight RJ; Toussi H; Srinivasan V
    Urol Int; 2006; 76(3):217-22. PubMed ID: 16601382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of 2001 Partin tables in Turkey: a multicenter study.
    Eskicorapci SY; Karabulut E; Türkeri L; Baltaci S; Cal C; Toktas G; Akpinar H; Ozer G; Sozen S; Tokuc R; Lekili M; Soylu A; Albayrak S; Sahin H; Alpar R; Ozen H
    Eur Urol; 2005 Feb; 47(2):185-9. PubMed ID: 15661412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor.
    Penson DF; Grossfeld GD; Li YP; Henning JM; Lubeck DP; Carroll PR
    J Urol; 2002 Apr; 167(4):1653-7; discussion 1657-8. PubMed ID: 11912382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
    Partin AW; Mangold LA; Lamm DM; Walsh PC; Epstein JI; Pearson JD
    Urology; 2001 Dec; 58(6):843-8. PubMed ID: 11744442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
    Augustin H; Eggert T; Wenske S; Karakiewicz PI; Palisaar J; Daghofer F; Huland H; Graefen M
    J Urol; 2004 Jan; 171(1):177-81. PubMed ID: 14665871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
    Eifler JB; Feng Z; Lin BM; Partin MT; Humphreys EB; Han M; Epstein JI; Walsh PC; Trock BJ; Partin AW
    BJU Int; 2013 Jan; 111(1):22-9. PubMed ID: 22834909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
    Abdollah F; Schmitges J; Sun M; Thuret R; Djahangirian O; Tian Z; Shariat SF; Briganti A; Perrotte P; Montorsi F; Karakiewicz PI
    Urology; 2011 Dec; 78(6):1363-7. PubMed ID: 22137704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy.
    Sandeman K; Eineluoto JT; Pohjonen J; Erickson A; Kilpeläinen TP; Järvinen P; Santti H; Petas A; Matikainen M; Marjasuo S; Kenttämies A; Mirtti T; Rannikko A
    PLoS One; 2020; 15(7):e0235779. PubMed ID: 32645056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
    Huang Y; Isharwal S; Haese A; Chun FK; Makarov DV; Feng Z; Han M; Humphreys E; Epstein JI; Partin AW; Veltri RW
    BJU Int; 2011 May; 107(10):1562-9. PubMed ID: 20875091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
    Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
    AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.